LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.29
+0.24 (3.40%)
At close: Dec 20, 2024, 4:00 PM
7.24
-0.05 (-0.69%)
After-hours: Dec 20, 2024, 4:47 PM EST
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for LFST stock have an average target of 8.70, with a low estimate of 7.00 and a high estimate of 10. The average target predicts an increase of 19.34% from the current stock price of 7.29.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LFST stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | +37.17% | Dec 16, 2024 |
| Barclays | Barclays | Sell Maintains $6 → $7 | Sell | Maintains | $6 → $7 | -3.98% | Nov 11, 2024 |
| UBS | UBS | Hold Maintains $9 → $7.5 | Hold | Maintains | $9 → $7.5 | +2.88% | Aug 15, 2024 |
| Barclays | Barclays | Sell Maintains $8 → $6 | Sell | Maintains | $8 → $6 | -17.70% | Aug 9, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $10 | Buy | Reiterates | $10 | +37.17% | Apr 22, 2024 |
Financial Forecast
Revenue This Year
1.26B
from 1.06B
Increased by 19.26%
Revenue Next Year
1.42B
from 1.26B
Increased by 12.47%
EPS This Year
-0.20
from -0.51
EPS Next Year
-0.17
from -0.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.3B | 1.5B | 1.7B |
| Avg | 1.3B | 1.4B | 1.6B |
| Low | 1.2B | 1.3B | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 23.5% | 16.8% | 18.7% |
| Avg | 19.3% | 12.5% | 14.0% |
| Low | 13.2% | 6.5% | 8.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.17 | -0.08 | 0.01 |
| Avg | -0.20 | -0.17 | -0.08 |
| Low | -0.25 | -0.22 | -0.17 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.